CMHC Masterclass On Demand: The Nexus of Women's Health and Cardiometabolic Risk- Implications Across the Lifespan

Metabolic syndrome and associated comorbidities, such as cardiovascular disease, obesity and type 2 diabetes, are becoming more common in women of reproductive age and beyond. In addition to traditional cardiometabolic risk factors, additional risk factors, including pregnancy-related outcomes, gestational diabetes mellitus, polycystic ovary syndrome, and hormonal replacement therapy, confer important implications on women's cardiometabolic health across the lifespan.

Additionally, suboptimal cardiometabolic health, often manifested as an increase in body weight and decrease in muscle mass and bone density, can often impact overall reproductive health. During this Masterclass meeting, multidisciplinary expert faculty will provide valuable clinical pearls on how to address these unique challenges.

Target Audience

Endocrinologists, obstetricians, gynecologists, midwives, diabetologists, primary care physicians, cardiologists, lipidologists, and as well as nurses, nurse practitioners, dieticians, and pharmacists.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Discuss the epidemiology, impacts, demographics, and unique CVD risk factors in women across the age spectrum.
  • Recognize and identify symptoms and the clinical presentation of acute and chronic CVD in women.
  • Describe the risk of cardiometabolic disease in women due to PCOS and adverse pregnancy outcomes.
  • Outline the cardiometabolic safety of postmenopausal hormone therapy and contraception.
  • Identify individualized approaches for the screening and co-management of cardiometabolic risk and women’s health, including PCOS, postmenopausal symptoms, contraception, osteoporosis, infertility, and long-term pregnancy adverse outcomes.
Course summary
Available credit: 
  • 6.25 ACPE Pharmacy
  • 6.25 AMA PRA Category 1 Credit™
  • 6.25 ANCC
  • 6.25 CDE
  • 6.25 Participation
Course opens: 
04/23/2021
Course expires: 
04/23/2022
Rating: 
0

Pam R. Taub, MD, FACC (Chair)
Associate Professor of Medicine
Director of Step Family Foundation Cardiovascular Rehabilitation and Wellness Center
UC San Diego Health System
Division of Cardiovascular Medicine
La Jolla, CA

Afshan Hameed, MD, FACOG, FACC (Co-Chair)
Professor, Maternal Fetal Medicine and Cardiology
Director, Obstetrics & Quality Safety
University of California
Irvine, CA

C. Noel Bairey Merz MD, FACC, FAHA, FESC
Professor and Endowed Chair
Director, Barbra Streisand Women’s Heart Center
Director, Preventive Cardiac Center
Cedars-Sinai Smidt Heart Institute
Los Angeles, CA

Shaista Malik, MD, PhD, MPH, FACC
Associate Vice Chancellor
University of California
Irvine, CA

Anuja Dokras, MD, PhD
Professor of Obstetrics and Gynecology
Director PENN PCOS Program
University of Pennsylvania
Philadelphia, PA

Sara Gilbertson Mertz, CNM, PMH-C
Henry Ford Health System
Metro-Detroit, MI

Emily S. Jungheim, MD
Chief of Reproductive Endocrinology and Infertility in the Department of Obstetrics and Gynecology
Professor of Obstetrics and Gynecology (Reproductive Endo and Infertility)
Northwestern Feinberg School of Medicine
Chicago, IL

Rachel Perry, MD, MPH
Associate Professor of Obstetrics and Gynecology
University of California, Irvine
Orange, CA

Emily Ko, MD, MSCR
Assistant Professor, Gynecologic Oncology
University of Pennsylvania
Philadelphia, PA

Sunny Smith, MD
Clinical Professor in the Dept of Family Medicine and Public Health
UC San Diego School of Medicine
San Diego, CA

Angela Lowenstern, MD
Interventional/Structural Cardiology Fellow
Duke University
Durham, NC

 

 

 

ESTIMATED TIME TO COMPLETE ACTIVITY
6.25 hours

JOINT ACCREDITATION STATEMENT
image   image   image



In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Tarsus Cardio Inc. dba Cardiometabolic Health Congress (CMHC). Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING MEDICAL EDUCATION
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 6.25 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate. 

CONTINUING PHARMACY EDUCATION
Postgraduate Institute for Medicine designates this continuing education activity for 6.25 contact hour(s) (0.6 CEUs) of the Accreditation Council for Pharmacy Education.

This is an application-based activity. Universal Activity Numbers (UAN): # JA4008162-9999-21-2707-H01-P.

For Pharmacists: Upon completing the post-test and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 – 6 weeks.

CONTINUING DIETICIAN EDUCATION
This program offers 6.25 CPEUs for dieticians.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty
A full listing of faculty disclosures  can be downloaded here.

Planners and Managers
The PIM planners and managers have nothing to disclose. The CMHC planners and managers have nothing to disclose.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

METHOD OF PARTICIPATION & REQUEST FOR CREDIT
There are no registration fees for this activity. During the period April 23, 2021 through April 23, 2022, participants must read the learning objectives and faculty disclosures, study the educational activity, and complete the evaluation. Upon completing, your certificate will be available for print. For questions about receiving certificates, please contact us at CMHC_Eval@cardiometabolichealth.org.

For questions about the accreditation of this activity, please visit www.pimed.com.

For Pharmacists: Please complete the evaluation instructions above. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks.

Available Credit

  • 6.25 ACPE Pharmacy
  • 6.25 AMA PRA Category 1 Credit™
  • 6.25 ANCC
  • 6.25 CDE
  • 6.25 Participation
Please login or register to take this course.

There are no registration fees for this activity. Please enroll and proceed with the course instructions.

Required Hardware/software

A computer with an internet connection

Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser

Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.